secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2026-08-25T20:08:06+00:00
Accession:  0001140361-26-034320
Event type: leadership
Sentiment:  negative
Materiality: 0.70
Item codes: 2.05, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

PDS Bio cuts 36% of workforce, removes COO Toutain; $842K charge
----------------------------------------------------------------

- Board approved Aug 6, 2026; RIF affects ~36% of workforce; notified Aug 21, 2026; Q3 completion.
- Q3 2026 one-time charge ~$842K for severance and benefits; all cash expenditures.
- COO Stephan Toutain removed without cause Aug 21, 2026; gets 12 months base salary plus COBRA.
- RIF aligns operating expenses with strategic priorities focused on advancing PDS0301.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126034320/0001140361-26-034320-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126034320/ef20081077_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-034320

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer